Metabolic engineering of plant cells for the production of pharmaceuticals

Projektinformationen

HEIKO MICHAEL: RISCH

ID Finanzhilfevereinbarung: QLK4-CT-2002-51547

Startdatum 1 Januar 2003

Enddatum 31 Dezember 2004

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 130 768,00

EU-Beitrag € 130 768,00

Koordiniert durch

TECHNICAL RESEARCH CENTRE OF FINLAND
Finland

Ziel

The project aims at developing new technologies based on functional genomic in which transgenic plant cell cultures are producing high contents of known or novel secondary metabolites to be used as pharmaceuticals.

Wissenschaftliches Gebiet

• engineering and technology › industrial biotechnology › metabolic engineering
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-4. - Key action Environment and Health

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

TECHNICAL RESEARCH CENTRE OF FINLAND

• EU-Beitrag: Keine Daten
• Adresse: Tietotie 2 ; 02044 ESPOO ; Finnland
• Gesamtkosten: Keine Daten